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Introduction
Turner syndrome (TS) is a common chromosomal 
disorder occurring in 1:2500 female live births. The most 
common presenting symptom in girls with TS is short 
stature which is mild during early childhood but becomes 
more notable with age. Untreated females are reported 
to be approximately 18-20 cm shorter than the general 
population (1,2,3,4).
Growth curves are widely used in pediatric practice and 
are very important tools for the evaluation of child health 
(5,6,7,8,9). The curves proposed by international health 
organizations, such as the World Health Organization (10) 
and the Centers for Disease Control and Prevention (11), 
provide growth evaluation in children belonging to different 
ethnicities and socio-economic conditions. However, 
children with specific diseases (including TS) and having a 
specific growth pattern cannot be well assessed with the 
curves designed for healthy children. Thus, disease-specific 
growth charts are required for better evaluation of growth 
and response to growth-promoting therapies in certain 
diseases.
There are growth curves for girls with TS from different 
countries which are affected by ethnicity and genetic factors 
(12,13,14,15,16,17,18,19,20,21,22,23,24). Preliminary 
studies have revealed that patients with TS have a high 
incidence of obesity. Weight-associated height references 
are therefore required in this area (13,20,24,25). Currently, 
there are no population-specific growth standards that allow 
monitoring of the growth of Turkish TS patients of different 
ages or provide a basis for a fairly accurate prediction of 
their adult height. 
We therefore undertook a collaborative study to 
construct growth charts and reference equations for age-
matched height, weight and body mass index (BMI) values 
from 3 years of age to adulthood for spontaneous growth of 
Turkish girls with TS.
Methods
This study on the evaluation of nationwide data of 
patients with TS in Turkey, the details of which have been 
reported previously, was conducted by the Turkish Turner 
Syndrome Study Group (26). 
Patients and Data Collection
A total of 842 patients with TS, younger than 18 years 
of age, who presented to 35 different centers in Turkey 
between 1984 and 2014, were enrolled in this cross-
sectional study. The study was approved by the Ethics 
Committee of Gülhane Military Medical Academy.
A Case Recording Form (CRF) was created which 
contained data on height and weightat first admission. 
Physicians working in outpatient clinics for TS patients were 
asked to fill in these CRF forms. The data were collected 
by physicians who were chosen to be responsible for the 
registration at each center. The data were assessed by 
four physicians (EY, FD, ES and PC) experienced in TS and 
were uploaded to the online web registry system located in 
the web site www.favorsci.org by van expert on electronic 
CRF preparation (CA). Data entered in the registry was also 
checked for consistency by a research assistant (EY). 
A standard 30-cell karyotype analysis from peripheral 
blood was made in all patients. The diagnosis of TS 
was confirmed by reviewing all the reported karyotypes 
of cultured peripheral blood lymphocytes. Karyotypes of 
patients were assigned to numerical, structural and both 
numerical and structural abnormalities by a geneticist (DG).
Height and weight measurements taken according to 
standard techniques and recorded at presentation were 
collected retrospectively. After excluding the patients who were 
younger than 3 years of age and those with a history of growth-
promoting treatment (such as growth hormone, estrogen, 
oxandrolone), we enrolled a total of 717 patients in the study.
The height values were interpolated individually to the 
nearest of the defined ages by expressing the measured 
height values as standard deviation score (SDS) using the 
Turkish references for height. The weight measurements 
were interpolated to full age values using the same method 
as height-for-age (27). BMI was calculated by dividing the 
weight by the square height or length (kg/m2). The obtained 
reference curves for height-for-age, weight-for-age and BMI-
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for-age of girls with TS were compared with those of healthy 
Turkish girls (27). For each defined age, 3rd, 10th, 25th, 50th, 
75th, 90th and 97th percentile values were calculated by a 
statistician (MMM). For the specific percentile line, age ±6 
month data were taken.
Statistical Analysis
Construction of the centile curves was performed with 
the LMS Chart Maker Pro version 2.3 software program 
(The Institute of Child Health, London), which fits smooth 
centile curves to reference data using the LMS method. 
The smoothed centile curves of BMI were constructed by 
the LMS method. This method summarizes percentiles 
at each age based on the power of age-specific Box-Cox 
power transformations that are used to normalize data. 
These three quantities depend on age. The final curves 
of percentiles are produced by three smooth curves 
representing Lambda; skewness (L), Mu; median (M) and 
Sigma; coefficient of variation (S). The LMS transformation 
equation is: X=M (1+LSz)1/L L≠0 or X=M exp (Sz) L=0 
where X is the physical measurement and z is the z-score 
that corresponds to the percentile. The key task of the 
transformation was to estimate parameters L, M and S. 
With estimates of L, M and S, values of X are connected to 
the values of z through the above equation. The percentile is 
obtained from a normal distribution table where the z-score 
corresponds to the percentile of interest.
Results 
Karyotype analyses of the patients are shown in Table 1. 
Half of the patients had a 45,X chromosome constitution. 
Other karyotypes were as follows: 10.8%, 10.1% and 9.5% 
for 45,X/46,XX, 46,X,i (Xq) and 45,X/46,X,i (Xq), respectively.
Height-for-Age
The L, M, S values and percentile values, the height 
growth chart and the mean change in height SDS for 
Turkish girls with TS are shown in Table 2, Figures 1 and 2, 
respectively. The comparison of the mean height of TS girls 
with that of other nationalities and with an age-matched 
Turkish healthy population is shown in Figure 3.
All mean height values in TS patients were lower in 
comparison to the mean values of healthy girls. The mean 
height values from 3 years of age were lower than that of 
the general population and got lower by age. While height 
was under -2 SD at age 3 years, this decline got closer to 
-4 SD at about 13 years of age. From the age of 13, we 
observed that there was an increase of approximately 2.5-3 
cm per year in height without pubertal peak. Around the 
ages of 14-15, the height distribution showed that -1 SD and 
-2 SD values for Turner girls nearly equaled the -5 SD and 
-6 SD values for the age-matched healthy girls, respectively.
The mean height of Turkish girls with TS, computed 
at 18.0 years of age, was found to be 141.9±6.9 cm in 
this cohort study, representing a deficit of about 21.2 cm 
according to the population mean (163.1±5.9 cm). 
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Table 1. Distribution of Turner syndrome patients according to karyotype (n=842)
Non-Mosaic n (%) Mosaic n (%)
Aneuploidy 45,X 427 (50.7) 45,X/46,XX 91 (10.8)
- - 45,X/47,XXX 13 (1.5)
- - 45,X/46,XY 23 (2.7)
- - 45,X/46,XX/47,XXX 7 (0.8)
- 427 (50.7) - 134 (15.9)
Structural abnormality 46,X,i (Xq) 85 (10.1) 45,X/46,X,i (Xq) 82 (9.5)
46,X,del (Xp) 16 (1.9) 45,X/46,X,r (X) 29 (3.4)
46,X,del (Xq) 11 (1.3) 45,X/46,X,idic (Y) 11 (1.4)
46,X,r (X) 5 (0.6) 45,X/46,X,+mar 10 (1.2)
Others 14 (1.7) Others 18 (2.2)
- 131 (15.6) - 150 (17.8)
Total - 558 (66.3) - 284 (33.7)
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Weight-for-Age
The L, M, S values and percentile values, the weight 
growth chart and the mean change in weight SDS for the 
Turkish girls with TS are shown in Table 3, Figures 4 and 5, 
respectively. The mean weight of Turkish girls with TS as 
compared to the mean weight of healthy Turkish girls is shown 
in Figure 6. All mean weights at different ages were lower in 
comparison to healthy girls. Mean weight SDS values from 3 
years of age were lower than those of the general population 
and gradually decreased by age. At ages 16-17 years, the mean 
weight-for-age of TS girls was lower than the reference -2 SD, 
whereas thereafter, the weight distribution showed that +2 SD 
and -2 SD for Turner girls nearly approached the reference +1 
SD and -5 SD, respectively (27). 
The 50th percentile of weight, computed at 18.0 y of 
age, was 45.0 kg and below that of the healthy population 
in this cohort study. 
Body Mass Index-for-Age
The BMI distributions of the Turkish girls with TS are 
shown in Table 4, Figures 7 and 8. The mean BMI of Turkish 
girls with TS as compared to the mean BMI of healthy 
Turkish girls is shown in Figure 9. 
The mean BMI distribution for TS at 3 years of age 
nearly approached the mean of the reference population 
and gradually increased by age. We also observed a plateau 
after 6 years of age, whereas thereafter, it always remained 
higher than the reference ranges. The BMI distribution 
showed that the +1 SD for Turner girls nearly equals the +2 
SD of the reference girls. 
Discussion
This study presents the growth data and growth curves 
of Turkish TS children. Three important considerations led 
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Table 2. Height of patients with Turner syndrome at different ages
Age
(Years) n L M S
Percentiles
Mean SD3 p 10 p 25 p 50 p 75 p 90 p 97 p
3 11 2.2 84.7 0.1 70.1 75.2 79.9 84.7 89.3 93.1 96.7 84.1 6.8
4 21 -0.1 91.2 0.1 79.9 83.3 86.9 91.2 95.8 100.2 104.7 91.7 6.3
5 31 -1.7 96.6 0.1 86.5 89.4 92.6 96.6 101.1 105.6 110.7 97.5 6.2
6 32 -2.2 101.4 0.1 91.9 94.6 97.6 101.4 105.8 110.3 115.4 102.4 6.0
7 51 -2.3 106.1 0.1 96.7 99.4 102.4 106.1 110.3 114.6 119.5 107.0 5.8
8 34 -2.0 110.7 0.1 101.2 103.9 107.0 110.7 114.8 118.9 123.4 111.4 5.7
9 61 -1.5 115.1 0.1 105.4 108.3 111.4 115.1 119.1 123.1 127.4 115.7 5.6
10 54 -0.9 119.3 0.0 109.3 112.3 115.5 119.3 123.3 127.2 131.2 119.7 5.6
11 72 -0.2 123.2 0.0 112.7 115.9 119.3 123.2 127.2 131.0 134.9 123.5 5.7
12 81 0.4 126.8 0.0 115.7 119.2 122.7 126.8 130.9 134.6 138.4 126.9 5.8
13 63 1.0 130.0 0.0 118.4 122.1 125.9 130.0 134.2 138.0 141.7 130.0 5.9
14 65 1.6 133.0 0.0 120.7 124.7 128.7 133.0 137.3 141.1 144.7 132.9 6.1
15 50 2.2 135.8 0.0 122.7 127.0 131.2 135.8 140.1 143.9 147.5 135.5 6.3
16 45 2.7 138.2 0.0 124.4 129.1 133.6 138.2 142.7 146.4 150.0 137.8 6.5
17 24 3.2 140.5 0.0 125.9 131.0 135.7 140.5 145.0 148.8 152.4 139.9 6.8
18 22 3.7 142.7 0.0 127.3 132.7 137.7 142.7 147.2 151.0 154.5 141.9 6.9
SD: standard deviation
187
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Table 3. Body weight of patients with Turner syndrome at different ages
Age
(Years) n L M S
Percentiles
Mean SD3 p 10 p 25 p 50 p 75 p 90 p 97 p
3 11 -2.7 10.5 0.3 7.4 8.0 8.9 10.5 14.3 15.1 17.4 11.7 2.5
4 21 -2.6 12.2 0.3 8.8 9.5 10.5 12.2 15.8 18.2 21.5 13.8 3.2
5 31 -2.5 14.0 0.3 10.2 11.0 12.1 14.0 17.5 20.7 24.9 15.8 3.7
6 32 -2.2 15.8 0.2 11.6 12.5 13.8 15.8 19.3 24.6 26.8 17.8 3.9
7 51 -1.9 17.1 0.2 13.1 14.2 15.7 17.9 21.5 27.3 31.7 20.2 4.7
8 34 -1.5 20.3 0.2 14.7 16.1 17.8 20.3 24 29.5 39.5 23.1 6.3
9 61 -1.2 22.9 0.2 16.4 18.0 20.0 22.9 26.9 32.2 40.5 25.3 6.1
10 54 -1.0 25.5 0.2 18.0 19.9 22.2 25.5 29.9 35.3 42.8 27.7 6.3
11 72 -0.1 28.1 0.2 19.6 21.8 24.5 28.2 32.9 38.4 45.6 30.1 6.6
12 81 -0.4 30.8 0.2 21.0 23.6 26.6 30.8 35.9 41.6 48.5 32.6 7.0
13 63 -0.2 33.3 0.2 22.4 25.3 28.8 33.3 38.8 44.6 51.5 35.0 7.4
14 65 -0.0 35.9 0.2 23.7 27.0 30.9 35.8 41.6 47.6 54.5 37.3 7.9
15 50 0.1 38.2 0.2 25.1 28.7 32.9 38.2 44.3 50.5 57.4 39.6 8.2
16 45 0.2 40.6 0.2 26.4 30.4 34.9 40.6 46.9 53.2 60.1 41.8 8.6
17 24 0.3 42.8 0.2 27.6 32.0 36.9 42.8 49.4 55.9 62.8 43.9 9.0
18 22 0.4 45.0 0.2 28.8 33.6 38.7 45.0 51.8 58.4 65.3 45.9 9.3
SD: standard deviation
Figure 1. Height percentiles of Turkish Turner syndrome girls 
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Figure 2. Mean change in height standard deviation scores of Turkish 
Turner syndrome girls 
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Table 4. Body mass index of patients with Turner syndrome at different ages
Age
(Years)
n L M S
Percentiles
Mean SD
3 p 10 p 25 p 50 p 75 p 90 p 97 p
3 11 -1.4 15.5 0.1 13.4 14.0 14.6 15.5 16.4 17.4 18.6 15.7 1.3
4 21 -1.3 15.7 0.1 13.3 14.0 14.7 15.7 16.9 18.1 19.6 16.0 1.6
5 31 -1.1 15.8 0.1 13.0 13.8 14.7 15.8 17.2 18.6 20.3 16.2 1.9
6 32 -1.1 16.0 0.1 12.9 13.7 14.7 16.0 17.5 19.2 21.1 16.4 2.1
7 51 -1.0 16.3 0.1 12.9 13.9 14.9 16.3 18.1 19.9 22.2 16.9 2.4
8 34 -0.9 16.9 0.1 13.1 14.1 15.3 16.9 18.8 20.9 23.5 17.5 2.7
9 61 -0.9 17.5 0.2 13.4 14.5 15.8 17.5 19.6 21.9 24.8 18.2 2.9
10 54 -0.7 18.1 0.2 13.6 14.8 16.2 18.1 20.4 22.9 26.0 18.9 3.2
11 72 -0.6 18.7 0.2 13.9 15.2 16.7 18.7 21.1 23.8 27.0 19.5 3.3
12 81 -0.5 19.2 0.2 14.1 15.5 17.1 19.3 21.8 24.6 27.9 20.0 3.5
13 63 -0.4 19.8 0.2 14.3 15.8 17.5 19.8 22.5 25.3 28.6 20.5 3.6
14 65 -0.2 20.3 0.2 14.5 16.1 18.0 20.3 23.1 26.0 29.4 21.1 3.8
15 50 -0.2 20.8 0.2 14.8 16.4 18.4 20.8 23.7 26.7 30.1 21.6 3.9
16 45 -0.1 21.2 0.2 15.0 16.7 18.7 21.3 24.2 27.3 30.8 22.0 4.0
17 24 -0.1 21.7 0.2 15.2 17.0 19.1 21.7 24.8 27.9 31.5 22.5 4.2
18 22 -0.1 22.1 0.2 15.4 17.3 19.4 22.1 25.3 28.5 32.1 22.9 4.3
SD: standard deviation
Figure 4. Body weight percentiles of Turkish Turner syndrome girls
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Figure 3. The comparison of the mean height of Turner syndrome 
girls with that of other nationalities and age-matched healthy Turkish 
children 
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us to realize the need for TS-specific growth charts for the 
children of our community. 
Firstly, growth hormone (GH) and/or oestrogen, 
oxandrolone therapies, in addition to their favorable metabolic 
effects, are recommended to accelerate growth and final 
height in TS patients. However, supra-physiological GH 
dosages are usually necessary to induce height acceleration 
in these girls (28). The response to GH is rather variable 
depending on the different treatment protocols such as 
dosing regimens, adjuvant therapy with oxandrolone, age 
at start of GH therapy and management of puberty (29). 
Besides providing accurate information for the monitoring 
of growth in TS girls, TS-specific growth charts are also 
important in order to elucidate the response to growth-
promoting therapies. 
Secondly, many studies indicate that there may be 
associated autoimmune disorders such as Hashimoto 
thyroiditis and celiac disease that may further inhibit the 
growth of TS patients. Short stature and/or low growth 
velocity can be the primary or sole manifestation of these 
disorders. Thus, evaluating the growth pattern may also be 
helpful in establishing the early diagnosis and understanding 
Figure 6. The comparison of the mean weight of Turkish Turner 
syndrome girls with the age-matched healthy population
Figure 7. Body mass index percentiles of Turkish Turner syndrome 
girls 
Figure 9. The comparison of the mean body mass index of Turkish 
Turner syndrome girls with the age-matched healthy population
Figure 5. Mean change in weight standard deviation scores of Turkish 
Turner syndrome girls
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Figure 8. Mean change in body mass index standard deviation scores 
of Turkish Turner syndrome girls 
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the pathogenesis of associated disorders which might 
influence growth (30,31). The use of population-specific 
growth charts for the monitoring of growth in TS girls is 
therefore also recommended to detect the presence of an 
additional pathology (12).
Thirdly, girls with TS are prone to obesity because 
of excessive weight gain with a central or android fat 
distribution, particularly. This predisposition to obesity may 
be exaggerated in appearance by the characteristics of TS 
patients such as shield-like chest, stocky build and short 
stature with relatively short legs. The patients should be 
evaluated regularly with appropriate counseling to avoid 
obesity (32).
The growth pattern of patients with TS is characterized 
by intrauterine growth retardation, slow growth during the 
first three years of life, impaired pre-pubertal growth and 
lack of a pubertal growth spurt. In our cohort, the results 
indicated that height velocity declines after the first year of 
life progressively and is below -2 SD around 3-4 years of age. 
There is no significant pubertal growth spurt and the height 
SDS approaches -4 SD around age 12 years. However, the 
children continue to grow and reach a height SDS of -2.6 
SD at 18 years of age. This further gain in height SD is also 
observed in patients without any pubertal development 
due to two possible reasons. Firstly, hormones other than 
gonadal steroids contribute to the normal pubertal growth 
spurt in girls. Secondly, there may be some residual function 
of the ovaries in Turner patients at the time of puberty and 
bone is more sensitive to estrogens than is breast tissue. 
The spurt in height growth often occurring as the first sign 
of puberty in normal girls is a finding which is in support of 
this latter theory (14,29,33,34). 
Ethnicity and genetic factors are important determinants 
of the growth curves for girls with TS. For instance, 
studies reveal that Japanese patients were shorter than the 
European patients (35). Therefore, country-specific growth 
curves should be generated. The comparison of our growth 
charts to two previously created percentile curves (by Lyon 
et al (16) and Rongen-Westerlaken et al (35)) revealed 
that the mean height percentile of our patients is almost 
identical to that reported by the first group of researchers 
but significantly lower than that reported by the second one. 
Mean height at age 18 years was 141.9±6.9 cm in the 
present study. A previous study on 110 untreated Turkish 
Turner subjects reported a final height of 141.6±7.0 cm at 
23 years of age (1). The slightly higher final height in the 
present study might reflect a secular trend or might be due 
to the small number of subjects of age 18 in our study.
BMI provides more information than weight-for-age and 
should be used as an index of adiposity in children. We 
constructed disease-specific charts for both weight-for-age 
and BMI in girls with TS. Several studies have shown that 
in general, the mean and SD values for weight in TS girls 
tend to increase with age. In our study, we observed that 
the distribution of BMI values gradually increased with 
age and that a +1 SD value for Turner girls nearly equals 
a +2 SD value for the reference for normal Turkish girls. 
Further studies are needed to reveal which method is more 
effective in interpreting the relationship between weight 
and height in girls with TS. In this study, our results indicate 
that the mean SD value for BMI increased around 2 years of 
age and remained higher than the general population (35).
The limitation of our study is its cross-sectional design 
and we have no data regarding growth velocity and 
spontaneous pubertal status. Moreover, it is not known 
whether subjects showing no signs of puberty at the time 
of registration will develop spontaneous puberty later. This 
is an important topic, because preliminary studies revealed 
that those with spontaneous puberty, from 12 years of 
age onward, are significantly taller than those without 
puberty, although pubertal development and growth spurt 
do not seem to affect final adult height (7). Nevertheless, a 
longitudinal study on spontaneous growth in TS would not 
be possible for ethical reasons.
In conclusion, we have presented cross-sectional data 
on the spontaneous growth of a large number of Turkish 
girls with TS. These growth charts will be useful in following 
the natural growth, weight gain and also the growth-
promoting effects of medical agents in these children. 
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